2-(1-Acetylhydrazino)-3-nitro-4-picoline
|
- $45 - $1028.16
- Product name: 2-(1-Acetylhydrazino)-3-nitro-4-picoline
- CAS: 1215205-33-6
- MF: C8H10N4O3
- MW: 210.19
- EINECS:
- MDL Number:MFCD13195787
- Synonyms:2-(1-Acetylhydrazino)-3-nitro-4-picoline;2-(1-Acetylhydrazino)-4-methyl-3-nitropyridine;N-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide;Acetic acid, 1-(4-methyl-3-nitro-2-pyridinyl)hydrazide
4 prices
Selected condition：
Brand
- AK Scientific
- Alichem
- Crysdot
- TRC
Package
- 1mg
- 100mg
- 1g
- ManufacturerAK Scientific
- Product numberZ8353
- Product descriptionN-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide
- Packaging100mg
- Price$384
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1215205336
- Product descriptionN-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide
- Packaging1g
- Price$1028.16
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11328336
- Product descriptionN-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide 95+%
- Packaging1g
- Price$944
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM340165
- Product descriptionN-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide
- Packaging1mg
- Price$45
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | Z8353 | N-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide | 100mg | $384 | 2021-12-16 | Buy |
| Alichem | 1215205336 | N-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide | 1g | $1028.16 | 2021-12-16 | Buy |
| Crysdot | CD11328336 | N-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide 95+% | 1g | $944 | 2021-12-16 | Buy |
| TRC | M340165 | N-(4-Methyl-3-nitropyridin-2-yl)acetohydrazide | 1mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :394.2±52.0 °C(Predicted)
Density :1.405±0.06 g/cm3(Predicted)
pka :0.06±0.10(Predicted)
Density :1.405±0.06 g/cm3(Predicted)
pka :0.06±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|